W WEST PHARMACEUTICAL SVSC INC
| Market Cap | $18.37B |
| P/E Ratio | 37.58 |
| Forward P/E | 28.78 |
| Dividend Yield | 0.35% |
| Beta | 1.15 |
| 52W Range | $189.72 - $306.73 |
| # Hedge Funds | 3 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
Hedge Fund Ownership
| Investor 4 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Hillman Value Fund Hillman Capital Management | 1.54% | $2.45M | 8,906 | Reduce 13.31% |
| Bill & Melinda Gates Foundation Trust Gates Foundation Trust | 0.35% | $122.30M | 444,500 | — |
| Viking Global Investors Viking Global Investors | 0.22% | $81.17M | 295,028 | Buy |
| Henry Ellenbogen Durable Capital Partners | 0.00% | $0 | 0 | Sold |
Frequently Asked Questions
What is WST stock price today?
WEST PHARMACEUTICAL SVSC INC (WST) is currently trading at $254.80. The stock has a 52-week range of $189.72 to $306.73 and a market capitalization of $18.37B.
Is WST a good stock to buy in 2026?
WEST PHARMACEUTICAL SVSC INC has a P/E ratio of 37.6 (forward P/E: 28.8), a dividend yield of 0.35%, and 1-year performance of +16.2%. 4 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling WST stock?
There have been 0 insider transactions for WST in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has WST stock performed over the past year?
WEST PHARMACEUTICAL SVSC INC (WST) has returned +16.2% over the past 12 months. The stock traded between $189.72 and $306.73 during this period, and is currently at $254.80.
Which hedge funds own WST (WEST PHARMACEUTICAL SVSC INC)?
4 tracked hedge funds currently hold WST in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is WST's market cap and valuation?
WEST PHARMACEUTICAL SVSC INC (WST) has a market capitalization of $18.37B. The trailing P/E ratio is 37.6 and forward P/E is 28.8. The stock is classified in the Healthcare sector.
What is WST's revenue and profitability?
WEST PHARMACEUTICAL SVSC INC reported revenue of $3.07B with net income of $493.70M and a profit margin of 0.16%. The stock has a beta of 1.15.
What sector is WST in and who are its biggest institutional holders?
WEST PHARMACEUTICAL SVSC INC (WST) operates in the Healthcare sector. It is held by 4 tracked hedge funds. See the ownership table above for the complete list.